Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain;Utilización de recursos en una cohorte de pacientes con artritis reumatoide atendidos en área especializada de reumatología en España

Reumatologia Clinica

Volumn 1, Issue 3, 2005, Pages 142-149

  Ruiz Montesinos, M D ^a   Hernandez Cruz B ^a   Ariza Ariza, R ^a   Carmona, L ^b   Ballina, J ^b   Navarro Sarabia, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Costs; Resources; Rheumatoid arthritis

Indexed keywords

EID: 34547899763     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(05)72733-9     Document Type: Article

References (22)

1. Carmona L. Epidemiología de la artritis reumatoide. Rev Esp Reumatol 29 (2002) 86-89
2. Yelin E., Trupin L., Wong B., and Rush S. The impact of functional status and change in functional status on mortality over years among persons with rheumatoid arthritis. J Rheumatol 29 (2002) 1851-1857
3. Yelin E. Musculoskeletal conditions and employment. Arthitis Care Res 8 (1995) 311-317
4. Yelin E. Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl 68 (2003) 8-11
5. Yelin E., Herrndorf A., Trupin L., and Sonneborn D. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care. Arthritis Rheum 44 (2001) 1160-1169
6. Macarrón M.P., and Jover J.A. Impacto socioeconómico y costes. In: Laffon A., and Gómez-Reino J.J. (Eds). Artritis reumatoide (2003), Sociedad Española de Reumatología, Madrid 57-64
7. Palferman T.G. Principles of rheumatoid arthritis control. J Rheumatol Suppl 67 (2003) 10-13
8. Lajas C., Abasolo L., Boutayeb B., Hernández-García C., Carmon L., Vargas E., et al. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum 49 (2003) 64-70
9. Prashker M.J., and Meenan R.F. The total costs of drugs therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicity. Arthritis Rheum 38 (1995) 318-325
10. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
11. Esteve-Vives J., Batlle-Gualda E., Reig A., and The Grupo para la adaptación del HAQ a la población española. Spanish version of the Health Assessment Questionnaire: reliability, validity, and trancultural equivalency. J Rheumatol 20 (1993) 2116-2122
12. Alonso J., Prieto L., and Antó J.M. La versión española del SF-36 Health Survey: un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 104 (1995) 771-776
13. Badía X., Roset M., Montserrat S., Herdman M., and Segura A. The Spanish version of the EuroQol: a description and its applications. European Quality of Life Scale. Med Clin (Barc) 112 1 (1999) 79-85
14. Torrance G.W., Thomas W.H., and Sackett D.L. A utility maximization model for evaluation of health care programs. Health Ser Res 7 (1972) 118-133
15. Gabriel S.E., Crowson C.S., and O'Fallon W.M. Comorbidity in arthritis. J Rheumatol 26 (1999) 2475-2479
16. Guillemin F., Durieux S., Daures J.P., Lafuma A., Saraux A., Sibilia J., et al. Costs of rheumatoid arthritis in France: a multicenter, study of 1109 patients managed by hospital-based rheumatologists. J Rheumatol 31 (2004) 1297-1304
17. Griffiths R.I., Bar-Din M., MacLean C.H., Sullivan E.M., Herber R.J., and Yelin E.H. Medical resource use and costs among rheumatoid arthritis patients receiving modifying antirheumatic drug therapy. Arthritis Care Res 13 (2000) 213-226
18. Chevat C., Pene B.M., Al M.J., and Rutten F.F. Healthcare resource utilization and costs of treating NSAID- associated. Pharmacoeconomics 19 Suppl 1 (2001) 17-32
19. Gabriel S.E., Crowson C.S., Campion M.E., and O'Fallon W.M. Direct medical costs unique to people with arthritis. J Rheumatol 24 (1997) 719-725
20. Lanes S.F., Lanza L.L., Radensky P.W., Yood R.A., Meenan R.F., Walker A.M., et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 40 (1997) 1475-1481
21. Leardini G., Salaffi F., Montanelli F., Gerzeli S., and Canesi B. A multicenter cost of illness study on rheumatoid arthritis in Italy. Clin Exp Rheumatol 20 (2002) 505-515
22. Tornero J., Piqueras J.A., Carballo L.F., and Vidal J. Epidemiología de la discapacidad laboral debida a las enfermedades reumáticas. Rev Esp Reumatol 29 (2002) 373-384